Current Drug Therapy

杂志介绍

Current Drug Therapy杂志介绍

《Current Drug Therapy》是一本以English为主的未开放获取国际优秀期刊，中文名称目前的药物治疗，本刊主要出版、报道领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为0.3，最新CiteScore 指数为1.3。

英文介绍

Current Drug Therapy杂志英文介绍

Current Drug Therapy covers a wide range of research, including cancer, nanoparticles, liposomes, chemotherapy, bioavailability, nanotechnology, radiotherapy, Alzheimer's disease, diabetes, psoriasis, vaccines, drug resistance, oxidative stress, bevacizumab, quality from design, drug delivery, inflammation, nano medicine and other hot topics. These themes reflect the latest trends and cutting-edge research in the field of drug therapy.

This journal has a certain influence in the academic community, with an impact factor (2023) of 0.302. Although relatively low, it still plays an important role in the field of drug therapy. The papers published in journals undergo rigorous peer review to ensure their quality and academic value. In addition, the journal also emphasizes interaction with readers and authors, providing practical information such as submission experience sharing and author knowledge, which facilitates researchers to better understand and participate in the journal's submission and publication process.